AstraZeneca’s Joe Shields in the running for Lifetime Achievement Award

From EMMY-award winning filmmaker to - global digital strategist for a top-10 pharmaceutical company, AstraZeneca’s Joe Shields has forged an interesting path. He now faces 3 other contenders for the Lifetime Achievement Award at eyeforpharma’s inaugural Philadelphia Awards on April 7th. But has he done enough to take the prize?

 

The Philadelphia Awards are designed to recognize those in healthcare who focus and prioritize their work for the benefit of patients. Alongside Joe, Diego Miralles of Janssen, Ray Chepesiuk of PAAB and Matt Portch of Pfizer have been nominated by their peers. Shields is a leader in the design of many of AstraZeneca’s customer-centric marketing programs. He is also one of the architects of AstraZeneca’s new capabilities in Customer Experience, with an increased focus on delivering the company’s innovative science, products and services to patients.

Since the success of eyeforpharma’s first awards ceremony, held in Barcelona last year we are witnessing a new type of competition. Competition which drives, rather than pure company performance, more patient-focused work from an industry with a battered reputation.

The winner of the 2014 Lifetime Achievement Award, Patrick Cashman of Lundbeck, claimed, “It is so important that the pharmaceutical industry continue to focus on the patient journey and specifically the challenges faced by patients and their loved ones. This valuable recognition will encourage others to renew their efforts to serve patient needs.”

An all-inclusive list of eyeforpharma’s Philadelphia Awards 2015 can be found online here: http://www.eyeforpharma.com/philadelphia/awards-index.php

Details of how to attend the full event where all winners will be announced on April 7th are here: https://secure.eyeforpharma.com/philadelphia/register.php

For more information please contact the eyeforpharma Awards Manager, Jenna Gottscho on jenna@eyeforpharma.com or visit www.eyeforpharma.com/philadelphia/awards 

comments powered by Disqus